Sewoon Medical Co., Ltd (KOSDAQ:100700)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,430.00
-30.00 (-1.22%)
At close: Sep 3, 2026

Sewoon Medical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
13,89711,91212,16314,95710,40612,282
Depreciation & Amortization
3,2693,3203,4803,6483,8883,836
Loss (Gain) From Sale of Assets
-15.44-36.61-279.54-17.79-2.20.67
Asset Writedown & Restructuring Costs
-32.65-30.6--1.222-7.63
Provision & Write-off of Bad Debts
146.24-3.547.31-1.25-15.31-22.77
Other Operating Activities
129.031,822-2,2012,807-1,8612,413
Change in Accounts Receivable
-123.12-715.35620.44372.12-1,1501,672
Change in Inventory
-362.41,121-1,268203.91-1,1772,077
Change in Accounts Payable
-645.69305.51-356.95-92.73-418.94-271.82
Change in Other Net Operating Assets
-338.1678.391,0211,201-393.25-508.66
Operating Cash Flow
15,92517,77313,18623,0769,27921,469
Operating Cash Flow Growth
9.93%34.79%-42.86%148.71%-56.78%11.52%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,630-1,691-1,435-1,949-2,151-2,224
Sale of Property, Plant & Equipment
487.47370.891,127609.45369.82296.88
Sale (Purchase) of Intangibles
-91.91-8.8-216.2-6.59-17.12-265.02
Investment in Securities
-5,500-87.824,989-18,010-6,986
Other Investing Activities
-66.7487.30.27-12.842
Investing Cash Flow
-6,801-1,324-349.1523,642-19,821-9,177

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--252.41-254.62-295.87-297.92-275.49
Total Debt Repaid
-266.83-252.41-254.62-295.87-297.92-275.49
Net Debt Issued (Repaid)
-266.83-252.41-254.62-295.87-297.92-275.49
Repurchase of Common Stock
-2,285-2,988----
Dividends Paid
-2,952-2,597-3,030-2,597-2,165-2,165
Financing Cash Flow
-5,504-5,838-3,285-2,893-2,462-2,440

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1,576314.5836.78-118.43156.3361.33
Miscellaneous Cash Flow Adjustments
-0-----
Net Cash Flow
5,19510,92610,38843,707-12,84910,213

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
14,29516,08311,75021,1277,12819,244
Free Cash Flow Growth
11.71%36.87%-44.38%196.41%-62.96%13.35%
Free Cash Flow Margin
21.49%25.26%19.54%30.96%11.86%30.75%
Free Cash Flow Per Share
338.67376.01271.47488.02164.65444.53
Levered Free Cash Flow
9,06612,6666,44416,3364,11516,161
Unlevered Free Cash Flow
9,08612,6896,46716,3584,13716,180

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
31.1635.5236.63---
Cash Income Tax Paid
2,8061,8234,6962,3604,9201,410
Change in Working Capital
-1,469789.4516.181,685-3,1392,968